TNF and rheumatoid arthritis: A cohort study conducted by Chen et al. [33] found that the risk of DM was low for RA or PS/PSA patients initiated with an anti-TNF agent and concomitant HCQ therapy followed by those who used HCQ without an anti-TNF agent.